NIH and West African leaders to discuss current crisis of Ebola outbreak at TJU

Leaders from West African Nations and representatives from the National Institutes of Health (NIH) will attend a meeting on September 22nd from 3:00-5:15 pm at Thomas Jefferson University to discuss the current crisis and plan future collaborations. Thomas Jefferson University is working with the National Institutes of Health to develop one promising Ebola vaccine candidate that could help prevent the spread of the disease.

There may be additional Ebola-related news announced at the meeting.

Speakers at the event will include His Excellency, Daouda Diabate, Ambassador from the Ivory Coast, Dr. Solange Ngazoa Kakou, Ph.D., Pasteur Institute Abidjan, Ivory Coast, as well as Stephen K. Klasko, M.D., M.B.A, President and CEO of Thomas Jefferson University and Jefferson Health System and Matthias J. Schnell, Ph.D., Professor, Microbiology and Immunology, Sidney Kimmel Medical College, TJU, Director, Jefferson Vaccine Center and co-inventor of the Jefferson Ebola vaccine with the NIH/NIAID. Kathleen E. Squires, M.D., Professor of Medicine, Sidney Kimmel Medical College, TJU, Division Director, Infectious Diseases and Environmental Medicine will also speak.

Speakers will discuss the current status of the Ebola outbreak in West Africa, including efforts to contain and prevent the spread of the disease. Dr. Schnell will address the current and future therapeutic strategies for the infection as well as work being done at Jefferson and the NIH on a promising vaccine approach.

The event will take place on September 22nd at 3:00-5:15pm at the Dorrance H. Hamilton Building, 1001 Locust Street, in Philadelphia, Pennsylvania.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17